Urinary chiro-inositol and myo-inositol excretion is elevated in the diabetic db/db mouse and streptozotocin diabetic rat

Experimental Biology and Medicine

Volumn 228, Issue 8, 2003, Pages 907-914

  Kawa, Julianne M ^a   Przybylski, Roman ^a   Taylor, Carla G ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Chiro inositol; db db mice; Diabetes; fa fa Zucker rats; Myo inositol; Streptozotocin rats; Urine

Indexed keywords

INOSITOL;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GAS CHROMATOGRAPHY; GLUCOSURIA; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; STREPTOZOCIN DIABETES; URINARY EXCRETION;

ANIMALIA; MAMMALIA;

EID: 0141736851     PISSN: 15353702     EISSN: None     Source Type: Journal    
DOI: 10.1177/153537020322800806     Document Type: Article

References (23)

1. Larner J, Huang LC, Schwartz CFW, Oswald AS, Shen T-Y, Kinter M, Tang G, Zeller K. Rat liver insulin mediator which stimulates pyruvate dehydrogenase phosphatase contains galactosamine and D-chiro-inositol. Biochem Biophys Res Commun 151:1416-1426, 1988.
2. Larner J, Huang LC, Suzuki S, Tang G, Zhang C, Schwartz CFW, Romero G, Luttrell L, Kennington AS. Insulin mediators and the control of pyruvate dehydrogenase complex. Ann N Y Acad Sci 573:297-305, 1989.
3. Beemster P, Groenen P, Steegers-Theunissen R. Involvement of inositol in reproduction. Nutr Rev 60:80-87, 2002.
4. 3H]inositol into phospholipid in the Goto-Kakizaki (G.K.) rat. Molecules and Cells 8:301-309, 1998.
5. 3H]chiroinositol in rat tissues. J Biol Chem 267:16904-16910, 1992.
6. Varela-Nieto I, Léon Y, Caro HN. Cell signalling by inositol phosphoglycans from different species. Comp Biochem Physiol 115B:223-241, 1996.
7. Field M. Is there evidence for phospho-oligosaccharides as insulin mediators? Glycobiology 7:161-168, 1997.
8. Jones DR, Varela-Nieto I. The role of glycosyl-phosphatidylinositol in signal transduction. Int J Biochem Cell Biol 30:313-326, 1998.
9. Jones DR, Varela-Nieto I. Diabetes and the role of inositol-containing lipids in insulin signaling. Mol Med 5:505-514, 1999.
10. Suzuki S, Taneda Y, Hirai S, Abe S, Saski A, Suzuki K, Toyota T. Molecular mechanism of insulin resistance in spontaneous diabetic GK (Goto-Kakizaki) rats. In: Saskamoto N, Angel A, Hotta N, Eds. New Directions in Research and Clinical Works for Obesity and Diabetes Mellitus. New York: Elsevier Science, pp197-203, 1991.
11. Sanchez-Arias J, Sanchez-Gutierrez J, Guadaño A, Alvarez J, Samper B, Mato J, Feliu J. Impairment of glycosyl-phosphatidylinositol-dependent insulin signaling system in isolated rat hepatocytes by streptozotocin-induced diabetes. Endocrinology 131:1727-1733, 1992.
12. Sánchez-Gutiérrez J, Sánchez-Arias J, Valle J, Guadaño A, Samper B, Mato J, Felíu J. Insulin resistance in genetically obese (fa/fa) rats: changes in the glycosyl-phosphatidylinositol signaling system in isolated hepatocytes. Endocrinology 134:1485-1492, 1994.
13. Asplin I, Galasko G, Larner J. Chiro-inositol deficiency and insulin resistance: a comparison of the chiro-inositol- and the myo-inositol-containing insulin mediators isolated from urine, hemodialysate, and muscle of control and type II diabetic subjects. Proc Natl Acad Sci U S A 90:5924-5928, 1993.
14. Shaskin PN, Shashkina EF, Fernqvist-Forbes E, Zhou Y-P, Grill V, Katz A. Insulin mediators in man: effects of glucose ingestion and insulin resistance. Diabetologia 40:557-563, 1997.
15. Kunjara S, Wang DY, Greenbaum AL, McLean P, Kurtz A, Rademacher TW. Inositol phosphoglycans in diabetes and obesity: urinary levels of IPG A-Type and IPG-P Type, and relationship to pathophysiological change. Mol Genet Metab 68:488-502, 1999.
16. Kennington AS, Hill CR, Craig J, Bogardus C, Raz I, Ortmeyer HK, Hansen BC, Romero G, Larner J. Low urinary chiro-inositol excretion in non-insulin-dependent diabetes mellitus. N Engl J Med 323:373-378, 1990.
17. Ostlund RE Jr, McGill JB, Herskowitz I, Kipnis DM, Santiago JV, Sherman W. D-chiro-inositol metabolism in diabetes mellitus. Proc Natl Acad Sci U S A 90:9988-9992, 1993.
18. Suzuki S, Kawasaki H, Satoh Y, Ohtomo M, Hirai M, Hirai A, Hirai S, Onoda M, Matsumoto M, Hinokio Y, Akai H, Craig J, Larner J, Toyota T. Urinary chiro-inositol excretion is an index marker of insulin sensitivity in Japanese Type II Diabetes. Diabetes Care 17:1465-1468, 1994.
19. Ortmeyer HK, Bodkin NL, Lilly L, Larner J, Hansen BC. Chiro-inositol deficiency and insulin resistance. I. Urinary excretion rate of chiro-inositol is directly associated with insulin resistance in spontaneously insulin-resistant Rhesus monkey. Endocrinology 132:640-645, 1993.
20. lck, a zinc-finger signal transduction protein, is elevated by dietary zinc deficiency and caloric deficiency in mice. J Nutr 129:620-627, 1999.
21. Meltzer S, Leiter L, Daneman D, Gerstein HC, Lau D, Ludwig S, Yale J-F, Zinman B, Lillie D. Steering and Expert Committees. 1998 Clinical Practice Guidelines for the Management of Diabetes in Canada. Can Med Assoc J 159(Suppl 8):S1-S28, 1998.
22. Portha B, Serradas P, Bailbé D, Suzuki K-I, Goto Y, Giroix M-H. β-Cell insensitivity to glucose in the GK rat, a spontaneous nonobese model for type II diabetes. Diabetes 40:486-491, 1991.
23. Niwa T, Yamamoto N, Maeda K, Yamada K. Gas chromatographic-mass spectrometric analysis of polyols in urine and serum of uremic patients. Identification of new deoxyalditols and inositol isomers. J Chromatogr 277:25-39, 1983.